Public Company

MTNL takes franchise route to sell 3G services

State run Mahanagar Telephone Nigam (MTNL) has taken to the franchise route to sell its 3G services in Delhi and Mumbai and has floated a global Expression of Interest (EoI) for 3G Services Franchisee. - Fin Min-led GOM to handle 3G spectrum issues - HC gives green signal for extension for MTNL chief - BSNL, MTNL drop '95' group dialling across the country - US markets mixed; Indian ADRs up - Govt mulls higher reserve price for 3G auctions - BSNL says Nokia Siemens did not meet tender requirement It has sought proposals for providing end-to-end services to 3G customers by Indian, global, subsidiary or JV companies as a 3G franchisee of MTNL in Delhi and Mumbai on exclusive revenue sharing basis through this EoI. This EoI is intended to seek proposals from prospective participants who have resources and infrastructure to acquire, serve and retain customers and provide customer care. The franchisees are also to set up their own payment collection system mechanism, create sales and distribution network to promote MTNL brand or create their own branding and marketing of 3G services and products. They are also to advise and package different tariff plans, Value Added Services and content services for 3G. With a penalty clause for missing targets, the PSU has set a target that includes assured revenue of Rs 240 crore in each metro over a three-year period. MTNL"s decision not to market its own 3G services after launching the service 6 months ago was taken after the company failed to acquire adequate amount of customers in the metros despite having the first mover advantage, said a private operator. With 3G spectrum auction for private players slated later this year and their services starting thereafter, MTNL has decided to get its branding and marketing act together before the first mover advantage goes out, the players said. Although the company says it is getting a good response to its 3G services, but reports say the number is below 1,000.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
Daiichi full-year losses narrow down to $2.2 bn
Japanese drug maker Daiichi Sankyo, which has a controlling stake in Indian pharma major Ranbaxy Laboratories, has narrowed its full-year losses at 215.59 billion yen (about $2.2 billion) on account of changes related to accounting guidelines in Japan.
Popular Articles

FIIs net buyers Rs 2,207cr in F&O on Tuesday
The Foreign Institutional Investors (FIIs) were net buyers of Rs 2,207.28 crore in futures and options segments on Tuesday.

3 Balco officials arrested for Korba chimney collapse
The police have finally arrested top officials of Vedanta Resources charged with the collapse of an under-construction power unit chimney at Bharat Aluminium Company (Balco) in September, killing 41 persons.